• 2c

Medline Programme

The Medline Programme is the medical line of predictive DNA tests aimed at the identification of the predisposition to common diseases among the World population, especially as far as the female gender is concerned. The Medline Programme DNA tests are an extension to the iGenesis Programme and need to be integrated in the broader context of health management and prevention.
The genetic tests belonging to this line represent the tool by which qualified specialists can introduce their patients to a personalized disease prevention plan.

 

MEDLINE OSTEO

Genetic predisposition to Osteoporosis and to articular cartilage damage

The Osteo DNA test deals with bone health and investigates individual predisposition to osteoporosis and articular cartilage damage.
The innovative genetic panel studied by DF Medica takes into consideration not only the Metabolism of Vitamin D and Calcium, but also hormonal factors: the Single Nucleotide Polymorphisms selected are all part of the same pathway involved in the regulation of the accumulation and in the turnover of bone mass.

Read more



MEDLINE H. THROMBOPHILIA

Genetic predisposition to Hereditary Thrombophilia

The H. Thrombophilia DNA test allows to identify individual predisposition to Hereditary Thrombophilia, a condition of increased thrombotic risk. The prevention plan related to this disease will take into consideration aspects and habits belonging to the everyday life of Women of every age, which, together with a genetic predisposition, could represent significant risk factors.

Read more

 The process

Either test of the Medline Programme follows a step-by-step process from DNA sampling to health prevention counselling.

prelievo

SAMPLING AND PERSONAL DATA TREATMENT
The DNA sample is collected through a simple and non-invasive method and sent to the molecular biology laboratory for genetic investigation.

Read more


risultato
GENETIC ANALYSIS AND FINAL REPORT
The DF Medica platform receives the encrypted data from the laboratory and elaborates such data on the basis of the algorithms set by the medical-scientific board. The reports are issued and sent in electronic form to the practitioner.

Read more



allenamento
PERSONALIZED HEALTH CONSELLING
The qualified expertise and the human relationship between the healthcare practitioners and patients represent the further added value in building the training program tailored on individual potential.

Approfondimento

 

 
dfmedicalogo50

Df Medica Oone Srl: 
Sede legale: Piazza San Giuseppe Moscati n. 5 • 82030 Apollosa (BN) • Italia
Uffici e magazzini: Via Pasubio n. 22 • 24025 Gazzaniga (BG) • Italia
P.IVA e C.F. n.IT02773630161 Capitale Sociale i.v. Euro 105.400,00 N.REA BN 142099
Tel. +39 035 7177011 • email: info@dfmedica.it • pec: oonesrl@propec.it
 

 

 

 

Press enter to search